• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性子宫切除术后早期宫颈癌的辅助治疗:我们是否过度治疗了患者?一项荟萃分析。

Adjuvant therapy in early-stage cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis.

机构信息

Unit of Gynecologic Oncology, Service of Gynecology, Vall d'Hebron Barcelona Hospital Campus, Autonoma University of Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Gynecology Department, Virgen de la Victoria University Hospital, Málaga, Spain.

出版信息

Clin Transl Oncol. 2022 Aug;24(8):1605-1614. doi: 10.1007/s12094-022-02808-9. Epub 2022 Apr 19.

DOI:10.1007/s12094-022-02808-9
PMID:35441353
Abstract

OBJECTIVE

There is a gap in knowledge regarding the ideal management of patients with early-stage cervical cancer and intermediate-risk features. Here, we present a meta-analysis of the published literature on oncological outcomes in these patients and determine trends in postoperative management.

METHODS

MEDLINE and PubMed were used for literature searches. The inclusion criteria were: English language articles including ≥ 10 patients, patients who underwent radical hysterectomy, nodes negative, studies reporting oncological outcomes and complications treatment-related and compare a surgery-only cohort with a radiotherapy cohort. The PRISMA guidelines were followed. Combined relative risk was calculated using DerSimonian-Laird random-effects model and a forest plot was drawn.

RESULTS

We collected 183 manuscripts on early-stage cervical cancer treated with radical hysterectomy alone or with adjuvant radiotherapy after surgery. A total of eight studies met the inclusion criteria. Regarding oncological outcomes, survival was reported in five studies. The relative risk of recurrence and the relative risk of mortality was similar in both groups independently whether receive or not adjuvant therapy. Most of the studies did not report significant differences regarding morbidity treatment related between the groups, except for a higher rate of lymphedema after radiotherapy.

CONCLUSION

We found that the relative risk of recurrence and mortality was similar in both groups not depending on adjuvant therapy. Therefore, whether radiotherapy adjuvant treatment is indicated remains a topic of debate.

摘要

目的

对于早期宫颈癌且具有中危特征的患者,其理想的管理方法尚存在知识空白。本研究对这些患者的肿瘤学结局相关已发表文献进行了荟萃分析,并确定了术后管理的趋势。

方法

使用 MEDLINE 和 PubMed 进行文献检索。纳入标准为:纳入≥ 10 例患者的英文文献、行根治性子宫切除术的患者、淋巴结阴性、报告肿瘤学结局和并发症治疗相关的研究,并比较单纯手术组和放疗组。遵循 PRISMA 指南。使用 DerSimonian-Laird 随机效应模型计算合并相对风险,并绘制森林图。

结果

我们收集了 183 篇关于早期宫颈癌的文章,这些文章均采用根治性子宫切除术单独治疗或术后辅助放疗。共有 8 项研究符合纳入标准。关于肿瘤学结局,5 项研究报告了生存率。是否接受辅助治疗,两组的复发相对风险和死亡相对风险均相似。除了放疗后淋巴水肿发生率较高外,大多数研究并未报告两组间与治疗相关的发病率存在显著差异。

结论

我们发现两组的复发和死亡相对风险相似,而这与辅助治疗无关。因此,是否需要辅助放疗仍然存在争议。

相似文献

1
Adjuvant therapy in early-stage cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis.根治性子宫切除术后早期宫颈癌的辅助治疗:我们是否过度治疗了患者?一项荟萃分析。
Clin Transl Oncol. 2022 Aug;24(8):1605-1614. doi: 10.1007/s12094-022-02808-9. Epub 2022 Apr 19.
2
Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.FIGO IIB期宫颈癌根治性子宫切除术联合辅助放疗与根治性放疗的比较
BMC Cancer. 2014 Feb 4;14:63. doi: 10.1186/1471-2407-14-63.
3
Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).FIGO IB1期宫颈癌且具有中度危险因素患者根治性子宫切除术后辅助放疗对结局和并发症影响的分析(GOTIC研究)
World J Surg Oncol. 2016 Jun 29;14(1):173. doi: 10.1186/s12957-016-0931-4.
4
The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.2018年国际妇产科联盟(FIGO)IB2期宫颈癌患者行根治性子宫切除术后的最佳肿瘤大小上限。
Int J Gynecol Cancer. 2020 Jul;30(7):975-980. doi: 10.1136/ijgc-2020-001271. Epub 2020 May 28.
5
Adjuvant platinum-based chemotherapy for early stage cervical cancer.早期宫颈癌的铂类辅助化疗。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD005342. doi: 10.1002/14651858.CD005342.pub2.
6
[Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].[新辅助化疗联合根治性子宫切除术治疗无高危因素的Ⅰb2期和Ⅱa2期宫颈鳞癌的预后分析]
Zhonghua Fu Chan Ke Za Zhi. 2018 Apr 25;53(4):248-256. doi: 10.3760/cma.j.issn.0529-567x.2018.04.008.
7
Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.根治性子宫切除术后辅助放疗在具有中度风险因素的淋巴结阴性ⅠB - ⅡA期宫颈癌中的作用。
J Med Assoc Thai. 2012 Mar;95 Suppl 3:S117-24.
8
Does the Robotic Platform Reduce Morbidity Associated With Combined Radical Surgery and Adjuvant Radiation for Early Cervical Cancers?机器人平台是否能降低早期宫颈癌联合根治性手术及辅助放疗的发病率?
Int J Gynecol Cancer. 2016 Oct;26(8):1485-9. doi: 10.1097/IGC.0000000000000775.
9
Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.针对IB2期宫颈癌的根治性子宫切除术和盆腔淋巴结清扫术。
Gynecol Oncol. 2004 May;93(2):429-34. doi: 10.1016/j.ygyno.2004.01.038.
10
Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.根治性子宫切除术联合个体化术后治疗在IB2期宫颈癌治疗中的应用:辅助治疗的可行性及指征
Gynecol Oncol. 2004 Jul;94(1):61-6. doi: 10.1016/j.ygyno.2004.04.016.

引用本文的文献

1
Management of Bulky Tumors in Cervical Cancer: Limits of the Surgical Approach.宫颈癌巨大肿瘤的管理:手术方法的局限性
J Clin Med. 2025 Feb 10;14(4):1142. doi: 10.3390/jcm14041142.
2
History and Perspectives of Hyperradical, Laterally Extended Parametrectomy (LEP).超广泛侧方广泛子宫颈旁切除术(LEP)的历史与展望。
Ann Surg Oncol. 2024 Oct;31(10):6984-6991. doi: 10.1245/s10434-024-16014-0. Epub 2024 Aug 21.
3
Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand.

本文引用的文献

1
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer.欧洲妇科肿瘤学会宫颈癌手术治疗质量指标。
Int J Gynecol Cancer. 2020 Jan;30(1):3-14. doi: 10.1136/ijgc-2019-000878.
2
Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature.“中危”淋巴结阴性宫颈癌患者行手术治疗且不进行辅助放疗的回顾性队列研究及文献复习。
Gynecol Oncol. 2018 Dec;151(3):438-443. doi: 10.1016/j.ygyno.2018.10.018. Epub 2018 Oct 20.
3
Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis.
泰国使用自我采集样本进行 HPV DNA 检测的宫颈癌筛查的成本效用和预算影响分析。
BMC Public Health. 2023 Dec 4;23(1):2413. doi: 10.1186/s12889-023-17358-0.
4
Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy.辅助放疗在接受根治性子宫切除术的宫颈癌患者中的作用。
J Pers Med. 2023 Oct 12;13(10):1486. doi: 10.3390/jpm13101486.
调强放疗根治宫颈癌的Meta 分析
Radiat Oncol. 2018 Sep 14;13(1):177. doi: 10.1186/s13014-018-1126-7.
4
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.《欧洲妇科肿瘤学会/欧洲放射肿瘤学会/欧洲病理学会宫颈癌管理指南》。
Int J Gynecol Cancer. 2018 May;28(4):641-655. doi: 10.1097/IGC.0000000000001216.
5
Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.降低原发性盆腔癌盆腔放疗急慢性胃肠道不良反应的干预措施。
Cochrane Database Syst Rev. 2018 Jan 23;1(1):CD012529. doi: 10.1002/14651858.CD012529.pub2.
6
2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy.2017 年关于根治性子宫切除术的 Querleu-Morrow 分类更新。
Ann Surg Oncol. 2017 Oct;24(11):3406-3412. doi: 10.1245/s10434-017-6031-z. Epub 2017 Aug 7.
7
Minimally invasive surgery using intraoperative electron-beam radiotherapy for the treatment of soft tissue sarcoma of the extremities with tendon involvement.使用术中电子束放射治疗对伴有肌腱受累的四肢软组织肉瘤进行微创手术。
World J Surg Oncol. 2016 Aug 12;14(1):214. doi: 10.1186/s12957-016-0968-4.
8
Radiotherapy and chemoradiation after surgery for early cervical cancer.早期宫颈癌术后的放射治疗与放化疗
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD007583. doi: 10.1002/14651858.CD007583.pub3.
9
Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.宫颈癌正电子发射断层扫描淋巴结分期与预后的关系。
J Clin Oncol. 2010 Apr 20;28(12):2108-13. doi: 10.1200/JCO.2009.25.4151. Epub 2010 Mar 22.
10
A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.一项前瞻性随机试验,旨在研究 MRI 检测到阳性盆腔而阴性腹主动脉旁淋巴结病的宫颈癌患者预处理 FDG-PET 的影响。
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):477-84. doi: 10.1016/j.ijrobp.2009.02.020. Epub 2009 May 21.